[PHARMA] QoQ TTM Result on 31-Dec-2018 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- -28.9%
YoY- -20.95%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 2,701,491 2,572,302 2,553,141 2,384,956 2,401,508 2,388,351 2,323,589 10.55%
PBT 58,549 72,267 71,756 70,220 78,146 75,814 73,994 -14.43%
Tax -24,693 -23,482 -26,467 -26,990 -17,398 -26,481 -20,676 12.55%
NP 33,856 48,785 45,289 43,230 60,748 49,333 53,318 -26.10%
-
NP to SH 33,816 48,386 44,499 42,468 59,731 48,260 52,386 -25.28%
-
Tax Rate 42.17% 32.49% 36.88% 38.44% 22.26% 34.93% 27.94% -
Total Cost 2,667,635 2,523,517 2,507,852 2,341,726 2,340,760 2,339,018 2,270,271 11.34%
-
Net Worth 516,387 518,564 528,825 509,862 522,618 519,642 524,838 -1.07%
Dividend
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Div 27,347 40,348 44,226 41,587 51,957 51,929 51,913 -34.74%
Div Payout % 80.87% 83.39% 99.39% 97.93% 86.99% 107.60% 99.10% -
Equity
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Net Worth 516,387 518,564 528,825 509,862 522,618 519,642 524,838 -1.07%
NOSH 261,229 261,229 260,505 260,505 260,505 259,821 259,821 0.36%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 1.25% 1.90% 1.77% 1.81% 2.53% 2.07% 2.29% -
ROE 6.55% 9.33% 8.41% 8.33% 11.43% 9.29% 9.98% -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 1,035.84 987.13 980.07 916.82 923.62 919.23 894.30 10.28%
EPS 12.97 18.57 17.08 16.33 22.97 18.57 20.16 -25.45%
DPS 10.50 15.50 17.00 16.00 20.00 20.00 20.00 -34.89%
NAPS 1.98 1.99 2.03 1.96 2.01 2.00 2.02 -1.32%
Adjusted Per Share Value based on latest NOSH - 260,505
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 187.44 178.48 177.15 165.48 166.63 165.72 161.22 10.55%
EPS 2.35 3.36 3.09 2.95 4.14 3.35 3.63 -25.14%
DPS 1.90 2.80 3.07 2.89 3.61 3.60 3.60 -34.66%
NAPS 0.3583 0.3598 0.3669 0.3538 0.3626 0.3606 0.3642 -1.08%
Price Multiplier on Financial Quarter End Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 -
Price 2.44 2.84 2.27 2.78 2.89 2.88 4.28 -
P/RPS 0.24 0.29 0.23 0.30 0.31 0.31 0.48 -36.97%
P/EPS 18.82 15.29 13.29 17.03 12.58 15.51 21.23 -7.71%
EY 5.31 6.54 7.53 5.87 7.95 6.45 4.71 8.31%
DY 4.30 5.46 7.49 5.76 6.92 6.94 4.67 -5.34%
P/NAPS 1.23 1.43 1.12 1.42 1.44 1.44 2.12 -30.41%
Price Multiplier on Announcement Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 20/11/19 23/08/19 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 -
Price 2.21 2.66 2.36 2.76 3.09 3.11 4.07 -
P/RPS 0.21 0.27 0.24 0.30 0.33 0.34 0.46 -40.68%
P/EPS 17.04 14.33 13.82 16.91 13.45 16.74 20.19 -10.68%
EY 5.87 6.98 7.24 5.92 7.43 5.97 4.95 12.02%
DY 4.75 5.83 7.20 5.80 6.47 6.43 4.91 -2.18%
P/NAPS 1.12 1.34 1.16 1.41 1.54 1.56 2.01 -32.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment